Publications
These publications represent just a selection of Dr. Ayala’s extensive research contributions in cancer biology and pathology, highlighting his work on tumor progression, nerve–cancer interactions, and prostate cancer:
- Hoover G, Gilbert S, Curley O, et al. Nerve-to-cancer transfer of mitochondria during cancer metastasis. Nature (2025).
https://doi.org/10.1038/s41586-025-09176-8
PubMed: https://pubmed.ncbi.nlm.nih.gov/40562940/ - Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature. Cancer (2009).
https://doi.org/10.1002/cncr.24396
PubMed: https://pubmed.ncbi.nlm.nih.gov/19484787/ - Ayala G. Neuroepithelial Interactions in Cancer. Annual Review of Pathology (2023).
https://doi.org/10.1146/annurev-pathmechdis-031521-023248
PubMed: https://pubmed.ncbi.nlm.nih.gov/36323005/ - Chen D, Ayala GE. Innervating Prostate Cancer. New England Journal of Medicine (2018).
https://doi.org/10.1056/NEJMcibr1714003
PubMed: https://pubmed.ncbi.nlm.nih.gov/29443663/ - Miles B, Ittmann M, Wheeler T, et al. Moving Beyond Gleason Scoring. Arch Pathol Lab Med (2019).
https://doi.org/10.5858/arpa.2018-0242-RA
PubMed: https://pubmed.ncbi.nlm.nih.gov/30865488/ - Mistry S, Mayer W, Khavari R, et al. Who’s too old to screen? Prostate cancer in elderly men. Can Urol Assoc J (2009).
https://doi.org/10.5489/cuaj.1071
PubMed: https://pubmed.ncbi.nlm.nih.gov/19543463/ - Beltran H, Tomlins S, Aparicio A, et al. Aggressive variants of castration-resistant prostate cancer. Clin Cancer Res (2014).
https://doi.org/10.1158/1078-0432.CCR-13-3309
PubMed: https://pubmed.ncbi.nlm.nih.gov/24727321/ - Budoff JE, Kraushaar BS, Ayala G. Flexor carpi ulnaris tendinopathy. J Hand Surg Am (2005).
https://doi.org/10.1016/j.jhsa.2004.07.018
PubMed: https://pubmed.ncbi.nlm.nih.gov/15680567/ - Farach A, Ding Y, Lee M, et al. Neuronal Trans-Differentiation in Prostate Cancer Cells. Prostate (2016).
https://doi.org/10.1002/pros.23221
PubMed: https://pubmed.ncbi.nlm.nih.gov/27403603/ - Feng S, Agoulnik IU, Bogatcheva NV, et al. Relaxin promotes prostate cancer progression. Clin Cancer Res (2007).
https://doi.org/10.1158/1078-0432.CCR-06-2492
PubMed: https://pubmed.ncbi.nlm.nih.gov/17363522/